abstract |
The present invention provides oligonucleotide analogues comprising modified inter-subunit linkages and / or modified 3 'and / or 5'-terminal groups. The described compounds are useful in the treatment of diseases where inhibition of protein expression or correction of abnormal mRNA split products provides a beneficial therapeutic effect. |